BIOCON and NSE Related Headlines

Go Back

Oct 1, 2025 07:30AM Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars

BIOCON and NSE Related Press Releases

Go Back

Oct 1, 2025 07:30AM Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars

BIOCON and NSE Related SEC Filings

Go Back